Comparing two seizure drugs in people with glioma
Official title: Seizure Treatment in Glioma
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on .
The short version
This trial compares two seizure medicines in people with a brain tumor called glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are graded 1 to 4 by how fast they tend to grow. See the glossary.
Read our full plain-language summary
What the trial team says
Currently, treatment with a specific anti-epileptic drug mainly depends on the physicians' preference, as there are no studies supporting the use of one specific anticonvulsant in glioma patients. The overall aim of this randomized controlled trial is to directly compare the effectiveness of treatment with levetiracetam or valproic acid in glioma patients with a first seizure.
Key facts
- Registry number
- NCT03048084
- Stage of testing
- Phase 4
- Conditions studied
- Glioma
Where it is running
This trial lists 5 sites.
-
Netherlands
- Amsterdam UMC (Amsterdam)
- Medisch Spectrum Twente (Enschede)
- Leiden University Medical Center (Leiden)
- Erasmus Medical Center (Rotterdam)
- Haaglanden Medical Center (The Hague)
How to use this
Talk to your care team first. They know your history and can tell you whether this trial is worth your time.
Joining a trial is always your choice. A trial is a test, not a proven treatment. Being in one is not a promise that it will help you.
This page is built from the trial's listing on ClinicalTrials.gov, a service of the U.S. National Library of Medicine. That listing is the authority, and it may have changed since we last read it. We do not run this trial and we cannot enroll you in it.